Loading clinical trials...
Loading clinical trials...
Efficacy of Pericapsular Nerve Group Block After Total Hip Arthroplasty Surgery
Controlling pain after hip replacement surgery improves comfort and partient satisfaction. Pain after hip replacement has traditionally been managed using systemic pain medications including acetaminophen and non-steroidal anti-inflammatory drugs. A recent Cochrane review demonstrated that compared to systemic analgesia alone, peripheral nerve blocks reduce postoperative pain with moderate-quality evidence. Pericapsular Nerve Group block is a new technique allowing local anesthetic diffusion to femoral, obturator and accessory obturator nerves and providing a good analgesic effect for hip fracture surgery. Investigators hypothesized that the PENG block could be an interesting alternative to systemic analgesiscs for pain control after total hip replacement.
The aim of the study was to evaluate the efficacy of the PENG block for intra and postoperative pain control in total hip arthroplasty. it was a monocentric, randomized, controlled and double blind study. Patients scheduled for primary THA with lateral approach under general anesthesia. Premedication with IV midazolam 1 to 2 mg on arrival to operating theatre. general anesthesia was conducted using fentanyl, propofol and cisatracurium for induction and isoflurane for maintanance patients were randomized using a random table in two groups: * PENG Block group (PG) who received 2 mg.kg-1Ropivacaine in 40 ml of saline. * Placebo group (SG) who received 40 ml of saline. Postoperative analgesia started before extubation of the patient, with: * IV paracetamol 1g/6h in Day1 and oral paracetamol 1g/8h for 6 days. * non steroidal anti inflammatory drugs with IM piroxicam 20 mg on day one (at the end of surgery) and oral diclofenac 50 mg/12h for 3 days. * Morphine PCA for day 1 (24 H) and oral tramadol 50 mg/12h from day 2 to day 6.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Institut Kassab D'Orthopedie
Tunis, Tunisia
Start Date
April 30, 2020
Primary Completion Date
April 30, 2021
Completion Date
December 31, 2021
Last Updated
February 13, 2024
60
ACTUAL participants
Pericapsular nerve group block with saline solution
PROCEDURE
Pericapsular nerve group block with ropivacaine
PROCEDURE
Lead Sponsor
University Tunis El Manar
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07327463